Clinical Trial Update: A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients. [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating INFeD dosing schedules in patients with iron deficiency anemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• INFED (iron dextran)

Snippet

Sponsor: Sutter Gould Medical Foundation | Conditions: Anemia, Iron Deficiency | Phase 4 | Status: WITHDRAWN